(Gly²²)-Amyloid β-Protein (1-40) |
| カタログ番号GA20199 |
高度に神経毒性のある北極変異体（E22G）Aβは、可溶性および不溶性のβ-アミロイド集合体形成のメカニズムを研究するために使用されています。野生型Aβと同様に、北極変異体はGM1ガングリオシドが存在する場合に優先的に集合します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 175010-18-1
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
The highly neurotoxic arctic mutant (E22G) of Aβ has been used to study the mechanisms underlying the formation of soluble and insoluble β-amyloid aggregates. As the wild-type Aβ, the arctic mutant preferably assembles in the presence of
Review for (Gly²²)-Amyloid β-Protein (1-40)
Average Rating: 5 (Based on Reviews and 5 reference(s) in Google Scholar.)
Review for (Gly²²)-Amyloid β-Protein (1-40)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *